Serum Glypican-3 versus Alpha-fetoprotein in Patients with Hepatocellular Carcinoma on Top of HCV Related Liver Cirrhosis

Hepatocellular Carcinoma Detection in Hepatitis C Virus-Related Cirrhosis by Glypican-3

Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Diagnostic Accuracy of α-1-Acid Glycoprotein in Diagnosis of Hepatocellular Carcinoma

Value of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study

Serum Golgi protein 73 and glypican-3: early diagnostic biomarkers for hepatocellular carcinoma

Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

Alpha-L-Fucosidase Versus Alpha-Fetoprotein: A Comparative Study for Diagnosing Hepatocellular Carcinoma in Post-Viral Cirrhotic Patients

A COMPARATIVE STUDY OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF GOLGI PROTEIN 73 AND ALFA-FETO PROTEIN IN HEPATOCELLULAR CARCINOMA BEFORE AND AFTER THERAPEUTIC INTERVENTION

Predictive Value of Alpha-Fetoprotein Change Rates for Hepatocellular Carcinoma Recurrence After Liver Transplant